Injection of Nuclear Factor-Kappa B Decoy into the Sciatic Nerve Suppresses Mechanical Allodynia and Thermal Hyperalgesia in a Rat Inflammatory Pain Model

Study Design. In vitro and in vivo study of a rat inflammatory pain model using nuclear factor-kappa B decoy. Objectives. To investigate transduction efficiency of nuclear factor-kappa B decoy into dorsal root ganglion, both in vivo and in vitro, and to assess the suppression of inflammatory pain by nuclear factor-kappa B decoy. Summary of Background Data. Transcription factor nuclear factor-kappa B is reported to play a crucial role in regulating pro-inflammatory cytokine gene expression. We hypothesized that inhibiting nuclear factor-kappa B gene expression with nuclear factor-kappa B decoy may suppress inflammatory pain. Methods. Nuclear factor-kappa B decoy-fluorescein isothiocyanate (FITC) was induced in explant culture, endoneurally injected into the sciatic nerve, and its transduction efficiency into dorsal root ganglion measured. For behavioral testing, 12 rats received plantar injections of complete Freund's adjuvant and were divided into 3 groups: decoy group, single endoneural injection of 10 &mgr;L of nuclear factor-kappa B decoy (n = 4); saline group, single endoneural injection of 10 &mgr;L of saline (n = 4); and naïve group, untreated (n = 4). Behavioral testing was performed using von Frey filaments and a Hargreaves device with a heat source. Results. Total transduction efficiency of nuclear factor-kappa B decoy-FITC was 53.6% in vitro and 20.5% in vivo. No statistical differences were observed with respect to types of cell size distributions of all FITC-positive neurons. In behavioral testing, withdrawal latencies or thresholds significantly differed between the decoy group and the saline group from 2 to 14 days after surgery in the mechanical allodynia experiments, and from 2 to 3 days after surgery in the thermal hyperalgesia experiments. Conclusions. Nuclear factor-kappa B decoy was conveyed and transduced into dorsal root ganglion both in vivo and in vitro. Additionally, nuclear factor-kappa B decoy reduced mechanical allodynia and thermal hyperalgesia in the rat inflammatory pain model, suggesting that inhibition of nuclear factor-kappa B with nuclear factor-kappa B decoy may represent a key mechanism for mediating inflammation or reducing inflammatory pain.

[1]  T. Ogihara,et al.  In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction , 1997, Nature Medicine.

[2]  A. Manning,et al.  NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. , 2001, Journal of immunology.

[3]  S. Lawson,et al.  Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones. , 1985, The Journal of physiology.

[4]  H. Lee,et al.  Spinal NF‐kB activation induces COX‐2 upregulation and contributes to inflammatory pain hypersensitivity , 2004, The European journal of neuroscience.

[5]  R. Morishita,et al.  NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. , 2001, Neuroreport.

[6]  J. Weinstein,et al.  Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats , 2002, European Spine Journal.

[7]  James D. Kang,et al.  Herniated Lumbar Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin-6, and Prostaglandin E2 , 1996, Spine.

[8]  J. Lin,et al.  Activation of transcription factors of nuclear factor kappa B, activator protein-1 and octamer factors in hyperalgesia. , 2000, European journal of pharmacology.

[9]  A. Bierhaus,et al.  Cyclosporine a inhibits tissue factor expression in monocytes/macrophages. , 1996, Blood.

[10]  R. Meyer,et al.  Myelinated afferents signal the hyperalgesia associated with nerve injury , 1988, Pain.

[11]  J. Pfeilschifter,et al.  Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. , 1995, Biochemical and biophysical research communications.

[12]  Yuzuru Takahashi,et al.  Dermatomes and the central organization of dermatomes and body surface regions in the spinal cord dorsal horn in rats , 2003, The Journal of comparative neurology.

[13]  Weiya Ma,et al.  Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries , 1998, Brain Research.

[14]  M. Stacey,et al.  The Allergen Der p1 Induces NF-kB Activation through Interference with IkBα Function in Asthmatic Bronchial Epithelial Cells , 1997 .

[15]  J. Hampe,et al.  Activation of nuclear factor κB in inflammatory bowel disease , 1998, Gut.

[16]  James D. Kang,et al.  Herniated Cervical Intervertebral Discs Spontaneously Produce Matrix Metalloproteinases, Nitric Oxide, Interleukin‐6, and Prostaglandin E2 , 1995, Spine.

[17]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[18]  T. Ishizuka,et al.  Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action. , 1997, Biochimica et biophysica acta.

[19]  R. Morishita,et al.  NF-κB decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model , 2001 .

[20]  S. Ghosh,et al.  Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.

[21]  P. Tak,et al.  NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.

[22]  T. Kakiuchi,et al.  Inflammatory Cytokines in the Herniated Disc of the Lumbar Spine , 1996, Spine.

[23]  P. Tak,et al.  NF-κB: a key role in inflammatory diseases , 2001 .

[24]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[25]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[26]  P J Barnes,et al.  Nuclear Factor-kappa B , 2006 .

[27]  M. Stacey,et al.  The allergen Der p1 induces NF-kappaB activation through interference with IkappaB alpha function in asthmatic bronchial epithelial cells. , 1997, Biochemical and biophysical research communications.

[28]  A. Manning,et al.  NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes1 , 2001, The Journal of Immunology.

[29]  F. Cerveró,et al.  Mechanisms of allodynia: interactions between sensitive mechanoreceptors and nociceptors , 1996, Neuroreport.

[30]  A. Manning,et al.  AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. , 1998, Autoimmunity.